Home > Insider Trading > Filing (0000908662-14-000114)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1177648	Enanta Pharmaceuticals Inc	ENTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1571211	R. Jay Luly	C/O Enanta Pharmaceuticals, Inc. 500 Arsenal Street Watertown MA 02472	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-03-10	3,700	$37.61	565,638	No	4	S	Direct
Common Stock	Disposition	2014-03-10	3,615	$38.77	562,023	No	4	S	Direct
Common Stock	Disposition	2014-03-10	2,685	$39.32	559,338	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2013 to provide liquidity for tax payments due on account of options exercised in 2013.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.0700 to $38.0200, inclusive.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.1000 to $39.0900, inclusive.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.1200 to $39.5400, inclusive.